Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Global TMJ Disorders Market Research Report-Forecast till 2027

Published by Market Research Future Product code 1001558
Published Content info 111 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global TMJ Disorders Market Research Report-Forecast till 2027
Published: March 10, 2021 Content info: 111 Pages
Description

Market Overview

Global TMJ Disorders Market was valued at USD 650.07 Million in 2019 and is expected to register a CAGR of 4.18 % during the forecast period of 2020 to 2027. Temporomandibular joint and muscle disorders are referred to as TMJ disorder that causes pain in the muscles and joints jaw. The increasing introduction and rapid adoption of advanced treatments and easy availability of medicines, rising prevalence of TMJ disorders, and increase in healthcare expenditure are expected to propel the market growth during the review period.

The global TMJ Disorder Market is expected to register a healthy market growth owing to the increase in technological advancement and increasing prevalence of these disorders. The emergence of non-surgical and surgical treatment methods for TMJ disorders is expected to drive market growth during the review period. TMJ disorders are the second-most commonly occurring musculoskeletal conditions resulting in pain and disability. The occurrences of TMD peaks from the age of 20-40 years, and it is found to be more prevalent in women than men. Additionally, women who use supplemental estrogenic or oral contraceptives are more expected to seek treatment for these conditions. Therefore, the increasing prevalence of these disorders in these populations is further fuelling the market growth during the review period.

Market Segmentation

The Global TMJ Disorders Market has been classified into Type, treatment, and end-user.

Based on type segment, the Global TMJ Disorders Market, based on Type classified into myofascial Pain, Internal Derangement (ID), and Osteoarthritis.

In terms of treatment, the market has been divided into medication, therapies, surgical, and others. The medication segment is further sub-divided into pain relievers, anti-inflammatories, tricyclic antidepressants, muscle relaxants, and others.

Based on end-user, the global TMJ disorders market is segmented into hospitals and clinics, ambulatory surgery centers, academic institutes, and others.

Regional Analysis

Geographically, the Global TMJ Disorder Market has been classified into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas market has been divided into North America and Latin America, with the North America market further segmented into the US and Canada. The Americas is expected to dominate the global market owing to the largest share of 49.20% of the TMJ disorder market in 2019. This largest share is driven by the introduction and rapid adoption of advanced treatments in the region.

The European TMJ disorder market has been bifurcated into Western Europe and Eastern Europe. The Western Europe TMJ disorder market has further been divided into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. The TMJ disorder market in Asia-Pacific has been classified into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific. The Middle East & Africa TMJ disorder market has been segmented into the Middle East and Africa.

Major Players

The key players in the global TMJ Disorders market are: Abbott Laboratories, Sun Pharmaceutical Industries Limited, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Allergan, Bayer AG, Zydus Cadila, Mylan NV, Novartis International AG, and Jubilant Life Sciences Limited.

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Table of Contents

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

  • 1.1 OVERVIEW
    • 1.1.1 MARKET SYNOPSIS

2. MARKET INTRODUCTION

  • 2.1 SCOPE OF THE STUDY
  • 2.2 RESEARCH OBJECTIVE
  • 2.3 LIST OF ASSUMPTIONS & LIMITATIONS

3. RESEARCH METHODOLOGY

  • 3.1.1 OVERVIEW
  • 3.2 DATA MINING
  • 3.3 SECONDARY RESEARCH
  • 3.4 PRIMARY RESEARCH
    • 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
    • 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4. MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 INCREASING PREVALENCE OF TMJ DISORDERS
    • 4.2.2 TECHNOLOGICAL ADVANCEMENTS IN TREATMENT OPTION FOR TMJ DISORDERS
    • 4.2.3 RISING NUMBER OF CLINICAL TRIALS
    • 4.2.4 GOVERNMENT SUPPORT IN FAVOR OF TMJ DISORDERS
  • 4.3 RESTRAINTS
    • 4.3.1 POORLY UNDERSTOOD ETIOLOGY OF TMJ DISORDER
  • 4.4 OPPORTUNITIES
    • 4.4.1 RISING DEMAND FOR NON-INVASIVE TREATMENT MODALITIES FOR TMJ

5. MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D AND DESIGNING
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION & SALES
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 BARGAINING POWER OF SUPPLIERS
    • 5.2.2 BARGAINING POWER OF BUYERS
    • 5.2.3 THREAT OF NEW ENTRANTS
    • 5.2.4 THREAT OF SUBSTITUTES
    • 5.2.5 RIVALRY
  • 5.3 COVID-19 IMPACT ANALYSIS
    • 5.3.1 IMPACT ON SUPPLY CHAIN
    • 5.3.2 IMPACT ON DENTAL PRACTICES
    • 5.3.3 IMPACT ON REGION
    • 5.3.4 IMPACT ON PATIENT VISITS
  • 5.4 US EPIDEMIOLOGY DATA

6. GLOBAL TMJ DISORDERS MARKET, BY TYPE

  • 6.1 OVERVIEW
  • 6.2 MYOFASCIAL PAIN
  • 6.3 INTERNAL DERANGEMENT
  • 6.4 ARTHRITIS

7. GLOBAL TMJ DISORDERS MARKET, BY TREATMENT

  • 7.1 OVERVIEW
  • 7.2 MEDICATION
  • 7.3 THERAPIES
  • 7.4 SURGICAL TREATMENT

8. GLOBAL TMJ DISORDERS MARKET, END USER

  • 8.1 OVERVIEW
  • 8.2 HOSPITALS & CLINICS
  • 8.3 AMBULATORY SURGERY CENTER
  • 8.4 RESEARCH AND ACADEMIC INSTITUTES

9. GLOBAL TMJ DISORDERS MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 AMERICAS
    • 9.2.1 NORTH AMERICA
      • 9.2.1.1 US
      • 9.2.1.2 CANADA
    • 9.2.2 LATIN AMERICA
  • 9.3 EUROPE
    • 9.3.1 WESTERN EUROPE
      • 9.3.1.1 GERMANY
      • 9.3.1.2 FRANCE
      • 9.3.1.3 UK
      • 9.3.1.4 ITALY
      • 9.3.1.5 SPAIN
      • 9.3.1.6 REST OF WESTERN EUROPE
    • 9.3.2 EASTERN EUROPE
  • 9.4 ASIA-PACIFIC
    • 9.4.1 CHINA
    • 9.4.2 JAPAN
    • 9.4.3 INDIA
    • 9.4.4 AUSTRALIA
    • 9.4.5 SOUTH KOREA
    • 9.4.6 REST OF ASIA-PACIFIC
  • 9.5 MIDDLE EAST & AFRICA
    • 9.5.1 MIDDLE EAST
    • 9.5.2 AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 GLOBAL TMJ DISORDERS COMPANY RANKING ANALYSIS (2019)
  • 10.3 COMPETITIVE BENCHMARKING
    • 10.3.1 AGREEMENT
    • 10.3.2 ACQUISITION
    • 10.3.3 EXPANSION
    • 10.3.4 LAUNCH & APPROVAL

11. COMPANY PROFILE

  • 11.1 ABBOTT LABORATORIES
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS/SERVICES OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 SWOT ANALYSIS
    • 11.1.6 KEY STRATEGIES
  • 11.2 SUN PHARMACEUTICAL INDUSTRIES LIMITED
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS/SERVICES OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 SWOT ANALYSIS
    • 11.2.6 KEY STRATEGIES
  • 11.3 BRISTOL-MYERS SQUIBB COMPANY
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS/SERVICES OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 SWOT ANALYSIS
    • 11.3.6 KEY STRATEGIES
  • 11.4 TEVA PHARMACEUTICAL INDUSTRIES LTD
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS/SERVICES OFFERED
    • 11.4.4 TEVA PHARMACEUTICAL INDUSTRIES LTD: KEY DEVELOPMENTS
    • 11.4.5 SWOT ANALYSIS
    • 11.4.6 KEY STRATEGIES
  • 11.5 ALLERGAN
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS/SERVICES OFFERED
    • 11.5.4 ALLERGAN: KEY DEVELOPMENTS
    • 11.5.5 SWOT ANALYSIS
    • 11.5.6 KEY STRATEGIES
  • 11.6 BAYER AG
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 PRODUCTS/SERVICES OFFERED
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 SWOT ANALYSIS
    • 11.6.6 KEY STRATEGIES
  • 11.7 ZYDUS CADILA
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS/SERVICES OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 SWOT ANALYSIS
    • 11.7.6 KEY STRATEGIES
  • 11.8 MYLAN NV
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCTS/SERVICES OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 SWOT ANALYSIS
    • 11.8.6 KEY STRATEGIES
  • 11.9 NOVARTIS INTERNATIONAL AG
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCTS/SERVICES OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 SWOT ANALYSIS
    • 11.9.6 KEY STRATEGIES
  • 11.10 JUBILANT LIFE SCIENCES LIMITED
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS/SERVICES OFFERED
    • 11.10.4 KEY DEVELOPMENTS
    • 11.10.5 SWOT ANALYSIS
    • 11.10.6 KEY STRATEGIES

12. APPENDIX

  • 12.1 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 US EPIDEMIOLOGY DATA
  • TABLE 3 GLOBAL TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 4 GLOBAL TMJ DISORDERS MARKET, FOR MYOFASCIAL PAIN, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 5 GLOBAL TMJ DISORDERS MARKET, FOR INTERNAL DERANGEMENT, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 6 GLOBAL TMJ DISORDERS MARKET, FOR ARTHRITIS, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 7 GLOBAL TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 8 GLOBAL TMJ DISORDERS MARKET, FOR MEDICATION, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 9 GLOBAL TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 10 GLOBAL TMJ DISORDERS MARKET, FOR THERAPY, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 11 GLOBAL TMJ DISORDERS MARKET, FOR SURGICAL TREATMENT, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 12 GLOBAL TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 13 GLOBAL TMJ DISORDERS MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 14 GLOBAL TMJ DISORDERS MARKET, FOR AMBULATORY SURGERY CENTER, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 15 GLOBAL TMJ DISORDERS MARKET, FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 16 GLOBAL TMJ DISORDERS MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 17 AMERICAS: TMJ DISORDERS MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 18 AMERICAS: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 19 AMERICAS: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 20 AMERICAS: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 21 AMERICAS: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 22 NORTH AMERICA: TMJ DISORDERS MARKET, BY COUNTRY, 2017-2027 (USD MILLION)
  • TABLE 23 NORTH AMERICA: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 24 NORTH AMERICA: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 25 NORTH AMERICA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 26 NORTH AMERICA: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 27 US: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 28 US: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 29 US: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 30 US: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 31 CANADA: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 32 CANADA: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 33 CANADA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 34 CANADA: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 35 LATIN AMERICA: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 36 LATIN AMERICA: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 37 LATIN AMERICA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 38 LATIN AMERICA: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 39 EUROPE: TMJ DISORDERS MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 40 EUROPE: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 41 EUROPE: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 42 EUROPE: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 43 EUROPE: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 44 WESTERN EUROPE: TMJ DISORDERS MARKET, BY COUNTRY, 2017-2027 (USD MILLION)
  • TABLE 45 WESTERN EUROPE: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 46 WESTERN EUROPE: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 47 WESTERN EUROPE: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 48 WESTERN EUROPE: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 49 GERMANY: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 50 GERMANY: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 51 GERMANY: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 52 GERMANY: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 53 FRANCE: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 54 FRANCE: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 55 FRANCE: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 56 FRANCE: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 57 UK: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 58 UK: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 59 UK: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 60 UK: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 61 ITALY: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 62 ITALY: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 63 ITALY: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 64 ITALY: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 65 SPAIN: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 66 SPAIN: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 67 SPAIN: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 68 SPAIN: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 69 REST OF WESTERN EUROPE: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 70 REST OF WESTERN EUROPE: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 71 REST OF WESTERN EUROPE: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 72 REST OF WESTERN EUROPE: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 73 EASTERN EUROPE: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 74 EASTERN EUROPE: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 75 EASTERN EUROPE: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 76 EASTERN EUROPE: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 77 ASIA-PACIFIC: TMJ DISORDERS MARKET, BY COUNTRY, 2017-2027 (USD MILLION)
  • TABLE 78 ASIA-PACIFIC: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 79 ASIA-PACIFIC: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 80 ASIA-PACIFIC: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 81 ASIA-PACIFIC: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 82 CHINA: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 83 CHINA: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 84 CHINA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 85 CHINA: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 86 JAPAN: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 87 JAPAN: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 88 JAPAN: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 89 JAPAN: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 90 INDIA: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 91 INDIA: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 92 INDIA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 93 INDIA: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 94 AUSTRALIA: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 95 AUSTRALIA: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 96 AUSTRALIA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 97 AUSTRALIA: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 98 SOUTH KOREA: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 99 SOUTH KOREA: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 100 SOUTH KOREA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 101 SOUTH KOREA: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 102 REST OF ASIA-PACIFIC: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 103 REST OF ASIA-PACIFIC: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 104 REST OF ASIA-PACIFIC: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 105 REST OF ASIA-PACIFIC: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 106 MIDDLE EAST & AFRICA: TMJ DISORDERS MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 107 MIDDLE EAST & AFRICA: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 108 MIDDLE EAST & AFRICA: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 109 MIDDLE EAST & AFRICA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 110 MIDDLE EAST & AFRICA: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 111 MIDDLE EAST: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 112 MIDDLE EAST: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 113 MIDDLE EAST: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 114 MIDDLE EAST: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 115 AFRICA: TMJ DISORDERS MARKET, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 116 AFRICA: TMJ DISORDERS MARKET, BY TREATMENT, 2017-2027 (USD MILLION)
  • TABLE 117 AFRICA: TMJ DISORDERS MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION)
  • TABLE 118 AFRICA: TMJ DISORDERS MARKET, BY END USER, 2017-2027 (USD MILLION)
  • TABLE 119 GLOBAL TMJ DISORDERS COMPANY RANKING ANALYSIS (2019)
  • TABLE 120 AGREEMENT
  • TABLE 121 ACQUISITION
  • TABLE 122 EXPANSION
  • TABLE 123 LAUNCH & APPROVAL
  • TABLE 124 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED
  • TABLE 125 SUN PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCTS/SERVICES OFFERED
  • TABLE 126 BRISTOL-MYERS SQUIBB COMPANY: PRODUCTS/SERVICES OFFERED
  • TABLE 127 TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS/SERVICES OFFERED
  • TABLE 128 ALLERGAN: PRODUCTS/SERVICES OFFERED
  • TABLE 129 ALLERGAN: KEY DEVELOPMENTS
  • TABLE 130 BAYER AG.: PRODUCTS/SERVICES OFFERED
  • TABLE 131 ZYDUS CADILA: PRODUCTS/SERVICES OFFERED
  • TABLE 132 MYLAN NV: PRODUCTS/SERVICES OFFERED
  • TABLE 133 MYLAN NV: KEY DEVELOPMENTS
  • TABLE 134 NOVARTIS INTERNATIONAL AG: PRODUCTS/SERVICES OFFERED
  • TABLE 135 JUBILANT LIFE SCIENCES LIMITED: PRODUCTS/SERVICES OFFERED

LIST OF FIGURES

  • FIGURE 1 GLOBAL TMJ DISORDERS MARKET STRUCTURE
  • FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 3 MARKET DYNAMICS: GLOBAL TMJ DISORDERS MARKET
  • FIGURE 4 DRIVERS: IMPACT ANALYSIS
  • FIGURE 5 RESTRAINTS: IMPACT ANALYSIS
  • FIGURE 6 VALUE CHAIN: TMJ DISORDERS MARKET
  • FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: TMJ DISORDERS MARKET
  • FIGURE 8 GLOBAL TMJ DISORDERS MARKET, BY TYPE, 2019 AND 2027 (USD MILLION)
  • FIGURE 9 GLOBAL TMJ DISORDERS MARKET, BY TREATMENT, 2019 AND 2027 (USD MILLION)
  • FIGURE 10 GLOBAL TMJ DISORDERS MARKET, BY END USER, 2019 AND 2027 (USD MILLION)
  • FIGURE 11 GLOBAL TMJ DISORDERS MARKET, BY REGION, 2019 AND 2027 (USD MILLION)
  • FIGURE 12 AMERICAS: TMJ DISORDERS MARKET, BY REGION, 2019 AND 2027 (USD MILLION)
  • FIGURE 13 NORTH AMERICA: TMJ DISORDERS MARKET, BY COUNTRY, 2019 AND 2027 (USD MILLION)
  • FIGURE 14 EUROPE: TMJ DISORDERS MARKET, BY REGION, 2019 AND 2027 (USD MILLION)
  • FIGURE 15 WESTERN EUROPE: TMJ DISORDERS MARKET, BY COUNTRY, 2019 AND 2027 (USD MILLION)
  • FIGURE 16 ASIA-PACIFIC: TMJ DISORDERS MARKET, BY COUNTRY, 2019 AND 2027 (USD MILLION)
  • FIGURE 17 MIDDLE EAST & AFRICA: TMJ DISORDERS MARKET, BY REGION, 2019 AND 2027 (USD MILLION)
  • FIGURE 18 BENCHMARKING OF MAJOR COMPETITORS
  • FIGURE 19 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 20 ABBOTT LABORATORIES: SWOT ANALYSIS
  • FIGURE 21 SUN PHARMACEUTICAL INDUSTRIES LIMITED: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 22 SUN PHARMACEUTICAL INDUSTRIES LIMITED: SWOT ANALYSIS
  • FIGURE 23 BRISTOL-MYERS SQUIBB COMPANY: FINANCIAL OVERVIEW
  • FIGURE 24 BRISTOL-MYERS SQUIBB COMPANY: SWOT ANALYSIS
  • FIGURE 25 TEVA PHARMACEUTICAL INDUSTRIES LTD: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 26 TEVA PHARMACEUTICAL INDUSTRIES LTD: SWOT ANALYSIS
  • FIGURE 27 ALLERGAN: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 28 ALLERGAN: SWOT ANALYSIS
  • FIGURE 29 BAYER AG.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 30 BAYER AG.: SWOT ANALYSIS
  • FIGURE 31 ZYDUS CADILA: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 32 ZYDUS CADILA: SWOT ANALYSIS
  • FIGURE 33 MYLAN NV: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 34 MYLAN NV: SWOT ANALYSIS
  • FIGURE 35 NOVARTIS INTERNATIONAL AG: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 36 NOVARTIS INTERNATIONAL AG: SWOT ANALYSIS
  • FIGURE 37 JUBILANT LIFE SCIENCES LIMITED: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 38 JUBILANT LIFE SCIENCES LIMITED: SWOT ANALYSIS
Back to Top